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Synopsis: We reviewed the relationship between the size, number, and laterality of 
superficial groin lymph nodes and the staging and laterality of lower limb lymphedema 
and reported that the size and number of superficial groin lymph nodes was a factor 
associated with the development of lymphedema. 
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ABSTRACT 
Purpose: This study evaluated the relationships of the size and number of superficial 
groin lymph nodes with the lower limb lymphedema stage and thus examined the role 
of superficial lymphatic lymph nodes in secondary lymphedema development. 
Methods: We determined the number and size of superficial groin lymph nodes using 
horizontal plane computed tomography (CT) and the lymphedema stage in the lower 
limbs of 25 patients with gynecologic cancer. 
Results: The patients had an average of 2.92 (range, 1–7) superficial groin lymph 
nodes; the mean size of the 146 evaluated lymph nodes was 7.55 mm (range, 5–15 mm). 
In 19 of 25 patients (76%), the side with major edema contained fewer superficial groin 
lymph nodes. In total, 22 patients (88%) had fewer superficial groin lymph nodes or a 
smaller total lymph node size on the edematous dominant side. 
Conclusions: In this evaluation of the link between superficial groin lymph node 
laterality and secondary lymphedema staging, we found that patients with large lymph 
node numbers and sizes tended to present with a relatively earlier stage of lymphedema. 
Our results therefore suggest that the size and number of superficial groin lymph nodes 
affect the lymphedema stage. 
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Lymphedema can be classified roughly as primary lymphedema, which occurs 
without a particular cause, and secondary lymphedema, which is consequent to 
lymphadenectomy during malignant tumor resection, infection, or trauma.
1-3
Lymphedema can occur in various regions of the body, including the upper limbs,
4-8
lower limbs,
9-10
 external genitalia,
11
 lower abdomen, and head and neck region.
12
However, most cases of secondary upper limb lymphedema are attributed to axillary 
lymphadenectomy during breast cancer resection
13-15
, whereas most cases of lower limb
lymphedema are attributed to pelvic lymphadenectomy during gynecologic or urologic 
cancer resection
16-18
.
Lymphatic flow can also be classified as superficial lymphatic flow, which occurs in the 
skin and subcutaneous fat tissue, and deep lymphatic flow, which occurs in the muscle 
and deep anatomic structures
19-21
; notably, previous studies have used lymphatic
scintigraphy and indocyanine green fluorescence lymphography to demonstrate the 
former.
22-24
 Generally, lymphatic drainage network reconstruction is assumed to occur
via lymphatic neogenesis at the site of injury and at sites of other lymphatic outflow 
tracts that have been impeded by lymphadenectomy, infection, or injury. According to 
Kutuna, who conducted detailed examinations of lymphatic systems in a Japanese 
population, lymph flow in the lower limbs is refluxed through both superficial groin 
lymph nodes and the pelvic lymph nodes.
25
 Scaglioni et al. further reported connections
between the superficial and deep lymphatic system in the inguinal region. These 
findings suggest that superficial lymphatic flow in the groin plays an important role in 
the reconstruction of lymphatic circulation after malignant tumor resection with pelvic 
lymphadenectomy, as this procedure does not injure the superficial lymphatic flow.
26-27
To date, few reports have described the relationship betwe n superficial lymphatic flow 
and secondary lymphedema. Accordingly, this study aimed to examine the role of 
superficial lymphatic circulation in the development of secondary lymphedema. 
Therefore, we reviewed the relationship between superficial groin lymph node laterality 
(i.e., non-equal number/size of lymph nodes in each limb) and lower limb lymphedema 
staging in patients with secondary lymphedema. 
MATERIALS AND METHODS 
This study was performed under a protocol approved by the Okayama University 
Hospital ethics committee. Informed patient consent was deemed unnecessary for this 
study and was therefore not obtained. From January 2009 to June 2014, 373 patients 
with concerns regarding secondary lower limb lymphedema underwent follow-up 
evaluation at Okayama University Hospital. We retrospectively reviewed data of 
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patients who met the following selection criteria: history of gynecologic malignant 
tumor resection with pelvic lymph node dissection performed at our hospital, absence of 
superficial groin lymph node metastasis (determined using positron emission 
tomography), and a difference in lymphedema stage between the lower limbs. 
Regarding the latter factor, because the severity of cellulitis, prophylactic antibiotic use, 
radiotherapy dosage, chemotherapy, additional operative procedures for lymphedema 
(e.g., lymphaticovenular anastomosis) are considered factors affecting lymphedema 
staging, we decided to compare stage laterality within individual cases rather than 
differences in stage between individuals. A total of 25 patients were selected. For these 
patients, we evaluated the primary disease associated with lymphedema, cancer stage, 
bilateral lymphedema stage, history of chemotherapy and radiation therapy, and interval 
from the initial resection to lymphedema development (Table 1). 
In addition, we confirmed that pelvic lymph nodes were surgically resected and 
determined the metastatic positive rate and the sizes and number of superficial groin 
lymph nodes for each patient (Table 2). The number of pelvic lymph nodes resected 
during primary surgery was determined according to the postoperative pathological 
diagnosis. The number and sizes of superficial groin lymph nodes were determined 
using preoperative horizontal plane computed tomography (CT) images (Figures 1 and 
2). We defined superficial groin lymph nodes as those present in adipose tissue on the 
anterior surface of the fascia lata in the inguinal lower groin area (Figure 3) In addition, 
these nodes were larger than 5 mm, as preoperative CT was unable to identify smaller 
nodes (Figures 4 and 5). 
For lymphedema staging, we used the International Society of Lymphology 
classification. Stage was determined by examining clinical records and photographs 
obtained at the initial diagnosis (Table 3), and decisions were confirmed in consensus by 
three physicians. Regarding edema laterality, we defined the side with the higher stage 
as the dominant edema side, and the side with the lower stage as the inferior edema side. 
Data analysis 
A two-sided Student's t test was used to evaluate differences of in the pelvic lymph 
nodes resected from the dominant and inferior edema sides. Chi-square analyses (with 
Fisher’s transformation if necessary) were performed to evaluate the correlation of the 
presence or absence of lymph node metastases of the malignant tumor and the dominant 
edema side. A P value <0.05 was considered to indicate statistical significance. 
Furthermore, we calculated the correlation coefficient between the total size of the 
superficial groin lymph nodes and lower limb lymphedema staging to identify a 
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potential statistical relationship between these factors. 
RESULTS 
Patients in our study had the following primary disease diagnoses: cervical cancer, 15 
patients; endometrial cancer, 9 patients; and endometrial and ovarian cancer, 1 patient. 
All patients underwent pelvic lymphadenectomy during primary tumor resection, and a 
mean of 2.92 (range, 1–7) superficial groin lymph nodes were removed from each of the 
50 lower limbs of the patients. The mean size of the 146 resected lymph nodes was 7.23 
mm (range, 5–12 mm). Regarding laterality, 16 patients exhibited right leg-dominant 
edema, whereas 9 patients exhibited left leg-dominant edema (Table 1). The mean 
numbers of pelvic lymph nodes resected from the dominant and inferior edema sides 
were 19.4 (range, 7–40) and 15.5 (range, 6–26), respectively. Sixteen and 18 metastatic 
lymph nodes were observed at the dominant and inferior edema sides, respectively, and 
the corresponding mean numbers of pelvic metastatic lymph nodes were 0.64 (range, 
0–6) and 0.72 (range, 0–7), respectively. Notably, the sides did not differ significantly 
with respect to the resected pelvic lymph nodes (P = 0.5510) or pelvic lymph node 
metastasis (P = 0.2890); however, dominant edema side was found to contain fewer 
superficial groin lymph nodes in 19 of 25 patients (76%). Three (12%) of the remaining 
6 patients had equal numbers of lymph nodes in both legs, although the sum total size of 
the superficial lymph nodes was smaller on the dominant edematous side. In total, 22 
patients (88%) had either fewer superficial groin lymph nodes or a smaller total lymph 
node size on the dominant edema side. Using scatter plots, we determined a correlation 
coefficient between the sum total size of the superficial groin lymph nodes and the 
lymphedema stage of -0.2866 (Figure 6). The mean interval from initial resection to 
lymphedema development was 17 months. 
Representative case 
Seven years prior to our study, a 68-year-old woman had undergone radical 
hysterectomy with pelvic lymphadenectomy and postoperative radiotherapy for stage 
2B cervical cancer; at this time, 2 superficial groin lymph nodes (7 and 8 mm) in the 
right groin and 5 nodes (7, 8, 8, 9, and 10 mm) in the left groin were detected via 
preoperative CT, and the case was designated left superficial groin lymph node 
dominant. She developed right lower limb lymphedema at approximately 4 months 
postoperatively and experienced cellulitis of the right lower limb twice per year. 
Seven years after the initial surgery, during which the patient experienced no recurrence 
of cervical cancer, she underwent a checkup at our department. At that time, her right 
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limb exhibited stage 3 lymphedema whereas the left limb was not edematous. 
Conservative treatment for lymphedema was initiated after diagnosis. 
DISCUSSION 
According to previous reports, the incidence of lower limb lymphedema after 
gynecologic cancer resection ranges from 30% to 40%.
28
 In addition, individual cases
vary in terms of lymphedema development, elapsed time prior to edema onset, and 
edematous stage, even among patients who have undergone the same surgical procedure 
for the same type of cancer. Furthermore, although bilateral pelvic lymphadenectomy is 
primarily performed for patients undergoing surgical resection for gynecologic cancers, 
secondary lymphedema tends to develop differently in terms of both incidence and 
staging. These phenomena, which remain poorly understood, are thought to reflect 
inherent individual differences in lymphatic system function and even bilateral 
differences within an individual. We note that for almost all cases in our series, primary 
tumor resection and lymph node dissection were performed via a lower midline incision. 
This might have led to the formation of horizontal scars that could interrupt the flow of 
superficial lymph, thus accounting for some of the observed differences. 
Limitations of this study 
We further note that various factors might ultimately affect lymphedema. Therefore, we 
examined the relationship between lymphedema laterality and staging within the same 
patient, rather than comparing individual cases. Despite this precaution, some problems 
in this study can be attributed to the retrospective design. For example, different 
postoperative observation periods were implemented, and we did not perform 
lymphoscintigraphic evaluations of lymph flow. In addition, we did not evaluate 
symptoms of edema by measuring changes in the limb circumference/CT volume. 
Finally, the time to lymphedema onset varied considerably among individuals. In future, 
a prospective study of patients with gynecologic cancer who have undergone pelvic 
lymph node dissection, including a multivariable analysis of the above-mentioned risk 
factors, would be of interest. 
The interpretation of our study is also limited by the variability in reported CT findings. 
In addition, the retrospective nature precluded the detection of small lymph nodes (<5 
mm) or 2-dimensional measurements of lymph node size. Although we had wanted to 
evaluate lymphatic network function,
29
 this parameter cannot be measured using a static
imaging technique such as CT; accordingly, we instead selected a lymph node analysis. 
However, CT quantification of superficial groin lymph nodes might also be inaccurate, 
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especially with regard to the actual function and flow of the nodes. Generally, deep 
pelvic lymph nodes such as the obturator, internal and external iliac, and para-aortic 
lymph nodes are resected along with primary gynecologic cancers (e.g., cervical, 
endometrial, and ovarian cancer). However, it is not possible to define the number of 
lymph nodes after surgery using the postoperative statuses of the remaining deep lymph 
nodes/vessels. Accordingly, in this study we indirectly examined the relationship 
between secondary lymphedema and superficial groin lymph nodes via horizontal plane 
CT evaluations. Moreover, the extent of pelvic lymphadenectomy in individual cases is 
affected by both the primary disease and the tumor stage, as well as differences in 
surgeons’ skills. In the present study, we were not able to review the potential 
influences of these elements because of the limited number of included patients. 
Relationship between superficial groin lymph nodes and secondary lymphedema 
The restoration of lymphatic flow can be classified roughly as a return to either a 
superficial lymph course, which includes the superficial groin lymph nodes, or a deep 
lymph course, which includes pelvic lymph nodes. We note that these courses 
intercommunicate in the process of lymphatic fluid drainage into the thoracic duct.
25
Therefore, as deep lymph course lymphatics are resected during pelvic 
lymphadenectomy, the remaining superficial groin lymph nodes are expected to play an 
important role in the postoperative reconstitution of lymph flow. Based on this theory, 
conservative treatment, including manual lymphatic drainage, is often performed for 
patients with secondary lymphedema in an attempt to encourage the return of superficial 
lymphatic flow. Similarly, most surgical procedures intended to improve lymphatic 
flow, such as lymphaticovenular anastomosis and lymph node transfer, are performed in 
the skin and subcutaneous fat tissue.
30-31
Regarding the relationship between the number of lymph nodes and lymphatic function, 
a larger number of lymph nodes is generally thought to permit better lymphatic flow 
and function.
32-35 
In addition, larger lymph nodes are thought to provide better
lymphatic flow and function. However, evaluations of lymph node size should also 
consider the effect of lymph node metastasis. In the present series, no superficial groin 
lymph nodes were affected in metastatic cases. In addition, the rate of pelvic lymph 
node metastasis was very low and was not thought to affect unilateral edema dominance. 
Although this study focused on the function of superficial groin lymph nodes after 
pelvic lymphadenectomy, it is clear that lymphedema development involves various 
complex, interconnected elements. Additional factors that may be related to 
lymphedema development after gynecologic tumor resection and should therefore be 
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considered include the type of primary disease, tumor stage, presence of lymph node 
metastases, and lymphadenectomy. Moreover, previous studies have suggested other 
risk factors that might affect the development of secondary lymphedema, including age, 
obesity, and a history of radiation therapy. Furthermore, the present study indicates that 
a lack of development of superficial groin lymph nodes affects the severity of 
lymphedema.
In the present study, patients with a large total lymph node number and/or size tended to 
have present with relatively earlier-stage lymphedema; in other words, superficial 
lymph nodes are thought to affect the onset of secondary lymphedema. Accordingly, a 
weak negative correlation was confirmed between the sum total superficial lymph node 
size and lymphedema stage. However, the lymph node number and size varied 
considerably among our study subjects because the groin lymph nodes were counted 
pre-operatively and were thus not influenced by the number of resected pelvic nodes. As 
a result, an inter-case of the numbers of resected pelvic lymph nodes and superficial 
groin lymph nodes would lack relevance. 
CONCLUSIONS 
In this study, we reviewed the relationship between superficial groin lymph node 
laterality and secondary lymphedema staging after primary gynecologic tumor resection 
with pelvic lymphadenectomy. Our results suggest that the presence of superficial groin 
lymph nodes affects the severity of lymph dema. However, future large-scale 
prospective studies are needed to determine the risk factors of patients who undergo 
gynecologic cancer resection and more clearly identify patients at high risk for 
lymphedema development. 
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Figure legends 
Figure 1. 
Lymph node measurement using horizontal plane contrast-enhanced computed 
tomography, femoral bone neck level. 
Bilateral superficial groin lymph nodes are elliptical (yellow circle). 
Blood vessels (red arrow) are visible medial to each lymph node. 
Figure 2. 
Lymph node measurement using horizontal plane contrast-enhanced computed 
tomography, femoral bone metaphyseal level. 
The left superficial groin lymph node has a rounded shape and is 8 mm in size (yellow 
circle). 
Blood vessels (red arrow) are visible medial to each lymph node. 
Figure 3. 
Schema of the superficial groin lymph nodes. 
All lymph nodes within the dotted line are counted. 
Figure 4. 
Measurement of the sizes of round lymph nodes. 
Lymph node sizing was based on square dimensions, as shown. 
Figure 5. 
Measurement of the sizes of elliptical lymph nodes. 
Lymph node sizes were determined using the mean major and mean minor dimensions, 
as shown. 
Figure 6. 
Scatter plot analysis of the relationship between the sum total size of the superficial 
groin lymph nodes and the stage of lymphedema. 
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Figure 1.  
Lymph node measurement using horizontal plane contrast-enhanced computed tomography, femoral bone 
neck level.  
Bilateral superficial groin lymph nodes are elliptical (yellow circle).  
Blood vessels (red arrow) are visible medial to each lymph node.  
165x97mm (300 x 300 DPI) 
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Figure 2.  
Lymph node measurement using horizontal plane contrast-enhanced computed tomography, femoral bone 
metaphyseal level.  
The left superficial groin lymph node has a rounded shape and is 8 mm in size (yellow circle).  
Blood vessels (red arrow) are visible medial to each lymph node.  
167x100mm (300 x 300 DPI) 
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Figure 3.  
Schema of the superficial groin lymph nodes.  
All lymph nodes within the dotted line are counted. 
304x376mm (300 x 300 DPI) 
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Measurement of the sizes of round lymph nodes.  
Lymph node sizing was based on square dimensions, as shown. 
135x135mm (300 x 300 DPI) 
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Measurement of the sizes of elliptical lymph nodes.  
Lymph node sizes were determined using the mean major and mean minor dimensions, as shown. 
135x135mm (300 x 300 DPI) 
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Figure 6.  
Scatter plot analysis of the relationship between the sum total size of the superficial groin lymph nodes and 
the stage of lymphedema.  
489x280mm (300 x 300 DPI) 
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Table.1 Patient Treatment History 
No. Age Primary Disease 
Ca. 
Stage 
LE Stage 
CT RT 
Follow up 
time Right Left 
1 68 Cervical ca. 2B 3 0 － ＋ 5M 
2 31 Cervical ca. 2B 2L 1 ＋ ＋ 1Y 
3 33 Cervical ca. 1B 2L 1 － － 5Y 
4 59 Cervical ca. 2B 2L 1 ＋ ＋ 7M 
5 65 Cervical ca. 1B 2L 0 ＋ ＋ 6M 
6 51 
Endometrial ca. 
＋Ovarian ca 
1C 
＋1B 2L 0 
＋ － 2M 
7 67 Endometrial ca. 1B 2 1 ＋ ＋ 1Y 6M 
8 63 Endometrial ca. 1B 2 0 ＋ － 6M 
9 69 Endometrial ca. 2B 2 0 ＋ ＋ 3M 
10 60 Endometrial ca. 1B 1 0 ＋ － 7Y 8M 
11 74 Endometrial ca. 1C 1 0 ＋ － 6Y 6M 
12 71 Endometrial ca. 1C 1 0 － － 3M 
13 50 Cervical ca. 1B 1 0 ＋ ＋ 1M 
14 40 Cervical ca. 2B 1 0 － ＋ 1M 
15 32 Endometrial ca. 3C 1 0 － － 1M 
16 42 Cervical ca. 1B 1 0 ＋ ＋ 3M 
17 49 Cervical ca. 1B 0 1 － ＋ 5Y 
18 76 Endometrial ca. 1C 0 1 ＋ － 1M 
19 39 Cervical ca. 2B 0 1 ＋ ＋ 1M 
20 65 Endometrial ca. 1B 0 2 ＋ ＋ 6M 
21 45 Cervical ca. 1B 0 2 ＋ － 1M 
22 61 Cervical ca. 1B 1 2 ＋ ＋ 6M 
23 67 Cervical ca. 1B 0 2L ＋ － 1M 
24 57 Cervical ca. 1B 1 2L － ＋ 1M 
25 37 Cervical ca. 1B 1 2L － ＋ 8M 
ca.: carcinoma, LE: lymphedema, 2L: late stage 2, CT: chemotherapy, RT: radiation 
therapy, Follow up time: follow-up time from initial resection to lymphedema 
development, Y: year, M: month 
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Table 2 
Relationship between lymphedema stages and each lymph nodes 
No. Age Primary Disease 
LE Stage 
PLN and 
positive rate 
Number and Size (mm) of 
superficial groin lymph nodes 
Right Left Right Left Right Left 
Right Side Edema Dominant Cases 
1 68 Cervical ca. 3 0 1/23 0/17 2: 7, 8 5: 7, 8, 8,9, 10 
2 31 Cervical ca. 2L 1 1/25 0/20 4: 7, 9, 9, 11 
7: 6, 6, 7, 9, 9, 
10, 12 
3 33 Cervical ca. 2L 1 0/17 0/14 1: 6 1: 8 
4 59 Cervical ca. 2L 1 0/23 0/11 3: 6, 7, 9 4: 8, 8, 9, 10 
5 65 Cervical ca. 2L 0 1/13 2/17 2: 6, 7 2: 7, 7 
6 51 
Endometrial ca. 
＋Ovarian ca 2L 0 0/46 0/21 2: 6, 8 3: 6, 8, 9 
7 67 Endometrial ca. 2 1 0/14 0/10 1: 12 3: 9, 9, 11 
8 63 Endometrial ca. 2 0 0/18 0/13 4: 5, 5, 6, 9 5: 6, 6, 6, 8, 9 
9 69 Endometrial ca. 2 0 1/26 0/15 2: 6, 9 2: 6, 9 
10 60 Endometrial ca. 1 0 0/11 0/31 2: 8, 10 3: 7, 9, 10 
11 74 Endometrial ca. 1 0 0/29 0/15 1: 9 3: 6, 8, 9 
12 71 Endometrial ca. 1 0 0/14 0/9 2: 6, 6 5: 6, 7, 7, 7, 8 
13 50 Cervical ca. 1 0 0/23 0/24 1: 6 2: 7, 8 
14 40 Cervical ca. 1 0 6/24 7/26 3: 6, 8, 9 4: 6, 8, 8, 9 
15 32 Endometrial ca. 1 0 0/40 2/23 2: 5, 5 2: 7, 9 
16 42 Cervical ca. 1 0 0/17 2/16 2: 6, 9 4: 5, 6, 6, 9 
Left Side Edema Dominant Cases 
17 49 Cervical ca. 0 1 0/9 0/23 3: 6, 6, 7 3: 6, 6, 7 
18 76 Endometrial ca. 0 1 0/7 0/7 2: 8, 11 1: 5 
19 39 Cervical ca. 0 1 4/15 2/21 3: 5, 7, 9 4: 7, 7, 8, 10 
20 65 Endometrial ca. 0 2 0/11 0/14 2: 7, 9 1: 9 
21 45 Cervical ca. 0 2 1/15 3/29 4: 6, 7, 8, 9 3: 7, 7, 9 
22 61 Cervical ca. 1 2 0/6 1/7 2: 10, 12 1: 12 
23 67 Cervical ca. 0 2L 0/13 0/11 5: 7, 8, 9, 10, 10 4: 5, 6, 8, 10 
24 57 Cervical ca. 1 2L 0/14 0/14 2: 9, 11 1: 12 
25 37 Cervical ca. 1 2L 0/10 0/20 4: 5, 5, 7, 7 2: 5, 9 
LE: lymphedema, PLN and positive rate：pelvic lymph nodes resected at surgery and 
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metastatic positive rate 
Page 21 of 22
John Wiley & Sons, Inc.
Journal of Surgical Oncology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Table.3 International Society of Lymphology (ISL) lymphedema staging 
ISL 
stage 0 
A subclinical state where swelling is not evident despite impaired lymph transport. 
This stage may exist for months or years before edema becomes evident. 
ISL 
stage I 
This represents early onset of the condition where there is accumulation of tissue fluid 
that subsides with limb elevation. The edema may be pitting at this stage. 
ISL 
stage II 
Limb elevation alone rarely reduces swelling and pitting is manifest. 
ISL 
late stage II 
There may or may not be pitting as tissue fibrosis is more evident. 
ISL 
stage III 
The tissue is hard (fibrotic), and pitting is absent. Skin changes such as thickening, 
hyperpigmentation, increased skin folds, fat deposits, and warty overgrowths develop. 
Page 22 of 22
John Wiley & Sons, Inc.
Journal of Surgical Oncology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
